Markets:

Overview

News

Currencies

International

Treasuries

Qiagen N.V. Common Shares (NY:QGEN)

40.63 +0.85 (+2.14%)

Official Closing Price Updated: 6:30 PM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Qiagen N.V. Common Shares

< Previous 1 2 3 4 5 6 7 8 Next >

A Preview Of Qiagen's Earnings ↗

November 04, 2022

Qiagen (NYSE:QGEN) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Qiagen will report an...

Via Benzinga

QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast

October 21, 2022

From QIAGEN N.V.

Via Business Wire

Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely ↗

October 11, 2022

One analyst doubts any deal could come to fruition. If it did, it would make sense.

Via Investor's Business Daily

Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11 ↗

October 11, 2022

Reuters US-China Chip War: KLA Relaxes Chip Supply To China

Via Benzinga

QIAGEN Launches Syndromic Test For QIAstat-Dx For Six Pathogens Similar To Monkeypox ↗

August 16, 2022

Via Benzinga

Natera Clocks 28% Jump In Q1 Sales, Lifts FY22 Guidance ↗

May 06, 2022

Via Benzinga

Qiagen Posts Upbeat Q1 Earnings, Raises FY22 Outlook ↗

April 27, 2022

Via Benzinga

Bio-Rad Laboratories, Qiagen Mull Merger Of Equals ↗

October 11, 2022

Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all.

Via Benzinga

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗

September 27, 2022

Via Benzinga

COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗

September 23, 2022

The World Health Organization (WHO) warned that it struggles to identify and

Via Benzinga

IGI Inex Holding (UK) Becomes Strategic Investor in Quantumrock, Cementing Partnership Between Leading Global Investment Group and AI Asset Tech Frontrunners

September 16, 2022

Via ACCESSWIRE

QIAGEN Adds New Assays With CE-IVD Certification for NeuMoDx Integrated PCR System

September 15, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug

September 14, 2022

From QIAGEN N.V.

Via Business Wire

No More Free COVID-19 At-Home Tests, Federal Government Says ↗

August 29, 2022

CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au

Via Benzinga

QIAGEN Issues 2021 Sustainability Report

August 18, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency

August 15, 2022

From QIAGEN N.V.

Via Business Wire

Qiagen Posts Robust Q2 Non-COVID Sales Growth, Lifts Annual Guidance ↗

July 27, 2022

Qiagen N.V. (NYSE: QGEN) clocked Q2 FY22 revenues of $516 million, down 9% Y/Y, well above the consensus of $488.73 million.

Via Benzinga

QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service

July 27, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook

July 26, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases

July 19, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast

July 07, 2022

From QIAGEN N.V.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 21, 2022

Good morning, investor! We're back with a breakdown of the biggest pre-market stock movers for Tuesday to get the day started!

Via InvestorPlace

U.S. CDC Endorses the Use of Digital PCR Technology for Wastewater Surveillance of Infectious Diseases – Including COVID-19 Outbreaks

June 01, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN’s Eco-Friendlier Products Earn Prestigious ACT Label

May 19, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels

May 16, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.

May 11, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN Proposes Expansion of Supervisory Board

May 11, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR System

May 05, 2022

From QIAGEN N.V.

Via Business Wire

QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlook

April 26, 2022

From QIAGEN N.V.

Via Business Wire

Earnings Scheduled For April 27, 2022 ↗

April 27, 2022

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.